Details for New Drug Application (NDA): 050777
✉ Email this page to a colleague
The generic ingredient in PROTOPIC is tacrolimus. There are twenty drug master file entries for this compound. Thirty-five suppliers are listed for this compound. Additional details are available on the tacrolimus profile page.
Summary for 050777
Tradename: | PROTOPIC |
Applicant: | Leo Pharma As |
Ingredient: | tacrolimus |
Patents: | 0 |
Pharmacology for NDA: 050777
Mechanism of Action | Calcineurin Inhibitors |
Medical Subject Heading (MeSH) Categories for 050777
Suppliers and Packaging for NDA: 050777
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
PROTOPIC | tacrolimus | OINTMENT;TOPICAL | 050777 | NDA | Padagis Israel Pharmaceuticals Ltd | 45802-390 | 45802-390-00 | 1 TUBE in 1 CARTON (45802-390-00) / 30 g in 1 TUBE |
PROTOPIC | tacrolimus | OINTMENT;TOPICAL | 050777 | NDA | Padagis Israel Pharmaceuticals Ltd | 45802-390 | 45802-390-01 | 1 TUBE in 1 CARTON (45802-390-01) / 60 g in 1 TUBE |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;TOPICAL | Strength | 0.03% | ||||
Approval Date: | Dec 8, 2000 | TE: | AB | RLD: | Yes |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | OINTMENT;TOPICAL | Strength | 0.1% | ||||
Approval Date: | Dec 8, 2000 | TE: | AB | RLD: | Yes |
Expired US Patents for NDA 050777
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Leo Pharma As | PROTOPIC | tacrolimus | OINTMENT;TOPICAL | 050777-001 | Dec 8, 2000 | 5,385,907 | ⤷ Subscribe |
Leo Pharma As | PROTOPIC | tacrolimus | OINTMENT;TOPICAL | 050777-002 | Dec 8, 2000 | 5,665,727 | ⤷ Subscribe |
Leo Pharma As | PROTOPIC | tacrolimus | OINTMENT;TOPICAL | 050777-002 | Dec 8, 2000 | 5,385,907 | ⤷ Subscribe |
Leo Pharma As | PROTOPIC | tacrolimus | OINTMENT;TOPICAL | 050777-001 | Dec 8, 2000 | 5,665,727 | ⤷ Subscribe |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription